Clinical Trial Update: Protein-energy Oral Supplementation Enriched With Omega-3 Fatty Acids in Cardiac Cachexia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a protein-energy oral supplement enriched with omega-3 fatty acids for cardiac cachexia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Cachexia

Drugs mentioned

• Protein-energy oral supplementation enriched with Omega-3 fatty acids

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Cardiac Cachexia | Phase 3 | Status: TERMINATED